1-42556167-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001395517.1(CCDC30):c.902G>A(p.Gly301Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,609,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395517.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC30 | NM_001395517.1 | c.902G>A | p.Gly301Glu | missense_variant | 10/21 | ENST00000657597.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC30 | ENST00000657597.2 | c.902G>A | p.Gly301Glu | missense_variant | 10/21 | NM_001395517.1 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.000112 AC: 17AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000138 AC: 34AN: 246550Hom.: 0 AF XY: 0.000180 AC XY: 24AN XY: 133178
GnomAD4 exome AF: 0.000125 AC: 182AN: 1456982Hom.: 0 Cov.: 32 AF XY: 0.000132 AC XY: 96AN XY: 724632
GnomAD4 genome ? AF: 0.000112 AC: 17AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.437G>A (p.G146E) alteration is located in exon 5 (coding exon 4) of the CCDC30 gene. This alteration results from a G to A substitution at nucleotide position 437, causing the glycine (G) at amino acid position 146 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at